Based on record reviews, observations, interviews and review of the medical literature in Facts and Comparisons, Epocrates and Drugs.com, the facility failed to ensure Resident (R)67 did not have multiple drug therapies that could cause central nervous system depression for 1 of 6 residents reviewed for unnecessary medications. Findings include: Review of R67's Face Sheet revealed R67 was admitted to the facility on [DATE] with diagnoses including but not limited to schizophrenia and dementia. A review of R67's physician orders by the Medical Director (MD) revealed the following orders: Trazodone (an antidepressant) 50 mg (milligram) at bedtime prescribed 01/19/23 open ended (no end date) for insomnia. Melatonin 3 mg x2 at bedtime prescribed 01/24/23 open ended for insomnia. …
F675 citations in South Carolina
Quality of Life and Care Deficiencies
Honor each resident's preferences, choices, values and beliefs.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2023
South Carolina cites F675 more often than its own record predicts
5.19 times the share F675 takes of citations nationally.
Of every deficiency written in South Carolina in 2023, this is the portion that was F675.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What South Carolina surveyors wrote
F675 findings written in South Carolina, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else South Carolina surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction